InMode (NASDAQ: INMD)
InMode Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
InMode Company Info
InMode's platforms provide effective treatments for aesthetic conditions without requiring patients to go under a scalpel.
News & Analysis
3 Boneheaded Investing Mistakes I Pledge Not to Make (Again) in 2024 and Beyond
You should do your best to avoid making similar mistakes too.
2 Small-Cap Stocks With Big Potential in 2024
These companies could experience strong growth next year.
Got $5,000? Here's 3 Reasons to Buy InMode Stock Right Now
Significant drivers of growth are developing, and they'll soon yield fruit.
This 1 Number Shows Why InMode Stock Is a Buy
Revenue is picking up in one of its core segments for its long-term performance.
Is It Too Late to Buy InMode Stock?
Shares of the aesthetics industry's favorite medical technology provider are already up 64% over the past 12 months.
Here's Why I'm Buying (More) InMode Stock in August
There's an interesting catalyst in the making that might drive even more sales.
Why InMode Stock Flew to a New 52-Week High Today
How many surprises does this company have up its sleeve?
Is This the Best Healthcare Stock to Buy Right Now?
There are no shortage of reasons to be bullish about InMode.
Valuation
Earnings Transcripts
InMode (INMD) Q4 2023 Earnings Call Transcript
INMD earnings call for the period ending December 31, 2023.
InMode (INMD) Q3 2023 Earnings Call Transcript
INMD earnings call for the period ending September 30, 2023.
InMode (INMD) Q2 2023 Earnings Call Transcript
INMD earnings call for the period ending June 30, 2023.
InMode (INMD) Q1 2023 Earnings Call Transcript
INMD earnings call for the period ending March 31, 2023.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.